Biopharmaceutical Courier Market Size
| Study Period | 2020 - 2029 |
| Market Size (2024) | USD 7.09 Billion |
| Market Size (2029) | USD 10.72 Billion |
| CAGR (2024 - 2029) | 8.83 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Biopharmaceutical Courier Market Analysis
The Biopharmaceutical Courier Market size is estimated at USD 7.09 billion in 2024, and is expected to reach USD 10.72 billion by 2029, growing at a CAGR of 8.83% during the forecast period (2024-2029).
The market is driven by the growing demand for personalized medicine, which drives the biopharma market's growth. The market is also driven by the increasing use of biopharma for the treatment of cancer and diabetes, as well as for the treatment of psoriasis and rheumatoid arthritis.
The growing awareness among the general public about the efficacy and accessibility of biopharma is also driving the growth of this market. The increasing focus on rare diseases and orphan drugs drives the market.
Rare diseases often have small patient populations, and a huge unmet medical need exists. Governments and regulatory agencies worldwide are introducing incentives and streamlining regulatory processes to promote therapies for rare diseases.
In addition, biopharma companies are investing in research and development to develop orphan drugs that target rare diseases, which address critical medical needs and create opportunities for market growth.
Biopharmaceutical Courier Market Trends
Immense Growth Projection for the Cold Chain Segment
Healthcare spending is increasing rapidly in the region due to an aging population and rising disposable income. This will continue to be a key factor for the future of global pharmaceutical and biotech companies.
The Asia-Pacific region is rapidly becoming a hub for outsourcing pathology testing, drug manufacturing, and clinical trials. This has increased the demand for temperature-sensitive healthcare products such as vaccines, biopharma, and clinical trial material. These changes have led to increased regional cold storage facilities and more investment in ongoing infrastructure improvements. Governments of various Asian nations are improving the healthcare cold chain logistics service. The growing demand for biopharma and vaccines that require cold chains is increasing. The pharmaceutical industry is expanding to meet the growing healthcare needs of an ever-expanding population.
Stricter government restrictions on handling temperature-sensitive pharmaceutical items are limiting market expansion. Consistency in operational processes, security, temperature, pest management, and expensive operational costs also limit market expansion.
North America is Emerging as a Key Player in the Market
The increasing number of chronic diseases and the growing investments in R&D activities in the United States drive North America's biopharmaceutical market. The US biopharmaceutical market is expected to grow due to the rising number of chronic diseases, well-established biopharmaceutical companies, and the growth of biotech companies.
The growing geriatric population and the increased R&D activity in the United States will also contribute to the growth of the biopharma market. According to the latest data from the Centers for Disease Control & Prevention (CDC), coronary heart disease (CHD) is the most prevalent heart disease in the United States, with approximately 22.3 million adults aged 20 and above suffering from it.
The CDC data also shows that every 40 seconds, around 9,58,000 people suffer from a heart attack in the United States in a year. The high number of patients suffering from cardiovascular diseases means that advanced drugs must be available to treat them.
Biopharmaceutical Courier Industry Overview
The biopharmaceutical courier market is highly competitive and comprises numerous key players. The competition in the industry is driven by factors such as reliability, speed, temperature control capabilities, and compliance with stringent regulations.
The major players in the market include FedEx, DHL, UPS, World Courier, and Marken. Local and regional logistics players also significantly cater to the biopharmaceutical courier needs of specific markets.
Biopharmaceutical Courier Market Leaders
-
FedEx
-
DHL
-
UPS
-
World Courier
-
Marken
*Disclaimer: Major Players sorted in no particular order
Biopharmaceutical Courier Market News
- September 2023: Astellas Pharma, one of the largest pharmaceutical manufacturers in Europe, announced plans to construct a new EUR 330 million (USD 354.32 million) plant in the County Kerry, Ireland town of Tralee. The plant is expected to open in 2028, subject to planning consent, and Astellas plans to begin construction in 2024.
- September 2023: Avalon Pharma, Saudi Arabia’s largest pharmaceutical company by market value, announced plans to expand its production capacity and diversify its portfolio. The USD 26.7 billion Avalon 4 plant in Riyadh, Saudi Arabia, is dedicated to producing advanced oncology drugs and generic injectables.
Biopharmaceutical Courier Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
- 4.1 Current Market Scenario
- 4.2 Government Regulations and Initiatives
- 4.3 Technological Trends and Automation in the Industry
- 4.4 Insights into Startups and Venture Capital Funding in the Industry
- 4.5 Brief on Courier Rates
- 4.6 Elaboration on Storage Functions and Value-added Services in the Business
- 4.7 Impact of COVID-19 on the B2C CEP Market
5. MARKET DYNAMICS
-
5.1 Drivers
- 5.1.1 E-commerce Boom driving the market
- 5.1.2 Increasing demand from healthcare sector driving the market
-
5.2 Restraints
- 5.2.1 Regulatory challenges affecting the market
- 5.2.2 Infrastructure limitations hindering the growth of the market
-
5.3 Opportunities
- 5.3.1 Increasing demands from consumers
- 5.3.2 International expansion
-
5.4 Industry Attractiveness - Porter's Five Forces Analysis
- 5.4.1 Bargaining Power of Suppliers
- 5.4.2 Bargaining Power of Consumers/ Buyers
- 5.4.3 Threat of New Entrants
- 5.4.4 Threat of Substitute Products
- 5.4.5 Intensity of Competitive Rivalry
- 5.5 Value Chain/Supply Chain Analysis
6. MARKET SEGMENTATION
-
6.1 By Services
- 6.1.1 Transportation
- 6.1.2 Storage
- 6.1.3 Packaging, and Labeling
-
6.2 By Business
- 6.2.1 B2B
- 6.2.2 B2C
-
6.3 By Destination
- 6.3.1 Domestic
- 6.3.2 International
-
6.4 By Type of Operation
- 6.4.1 Cold Chain
- 6.4.2 Non Cold Chain
-
6.5 By Geography
- 6.5.1 Asia-Pacific
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Latin America
- 6.5.5 Middle East & Africa
7. COMPETITIVE LANDSCAPE
- 7.1 Overview (Market Concentration and Major Players)
-
7.2 Company Profiles
- 7.2.1 FedEx
- 7.2.2 DHL
- 7.2.3 UPS
- 7.2.4 World Courier
- 7.2.5 Marken
- 7.2.6 QuickSTAT
- 7.2.7 Cryoport
- 7.2.8 LifeConEx*
- *List Not Exhaustive
- 7.3 Other Companies
8. FUTURE OF THE MARKET
9. APPENDIX
** Subject To AvailablityBiopharmaceutical Courier Industry Segmentation
The biopharmaceutical courier market refers to the transportation and delivery services tailored explicitly for the biopharmaceutical industry. It provides specialized logistics solutions to ensure these products' safe and efficient delivery, maintaining the required temperature conditions and complying with regulatory standards.
The biopharmaceutical courier market is segmented by service (transportation, warehousing and distribution, and value-added services), business (B2B and B2C), destination (domestic and international), type of operation (cold chain and non-cold chain), and geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The market size and forecasts for all the above segments are in USD.
| By Services | Transportation |
| Storage | |
| Packaging, and Labeling | |
| By Business | B2B |
| B2C | |
| By Destination | Domestic |
| International | |
| By Type of Operation | Cold Chain |
| Non Cold Chain | |
| By Geography | Asia-Pacific |
| North America | |
| Europe | |
| Latin America | |
| Middle East & Africa |
Biopharmaceutical Courier Market Research FAQs
How big is the Biopharmaceutical Courier Market?
The Biopharmaceutical Courier Market size is expected to reach USD 7.09 billion in 2024 and grow at a CAGR of 8.83% to reach USD 10.72 billion by 2029.
What is the current Biopharmaceutical Courier Market size?
In 2024, the Biopharmaceutical Courier Market size is expected to reach USD 7.09 billion.
Who are the key players in Biopharmaceutical Courier Market?
FedEx, DHL, UPS, World Courier and Marken are the major companies operating in the Biopharmaceutical Courier Market.
Which is the fastest growing region in Biopharmaceutical Courier Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Biopharmaceutical Courier Market?
In 2024, the North America accounts for the largest market share in Biopharmaceutical Courier Market.
What years does this Biopharmaceutical Courier Market cover, and what was the market size in 2023?
In 2023, the Biopharmaceutical Courier Market size was estimated at USD 6.46 billion. The report covers the Biopharmaceutical Courier Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Biopharmaceutical Courier Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Biopharmaceutical Courier Industry Report
Statistics for the 2024 Biopharmaceutical Courier market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Biopharmaceutical Courier analysis includes a market forecast outlook for 2024 to 2029) and historical overview. Get a sample of this industry analysis as a free report PDF download.
